Back to today’s briefing

Story perspectives

Oprah Defends Paris Fashion Stroll Amid Health Struggles

3/16/2026

44 7 Full Breakdown

Summary

Story summary

Oprah Winfrey responded to criticism of her walking at Paris Fashion Week, explaining she could not see well because of new sunglasses and Gayle King's broken toes.
Earlier this month, she showcased weight loss by arriving in stylish attire.
In a recent interview, she said she will take GLP-1 (glucagon-like peptide-1) weight loss medication after years of obesity and urged others to seek information and choose their paths.

History

Historical Context

The FDA approved GLP-1 medications like Saxenda for obesity treatment in 2014, amid rising obesity rates, with 36.5% of U.S. adults classified as obese that year. This marked a shift towards pharmaceutical interventions for weight management, reflecting a broader acceptance of such treatments. Oprah Winfrey's endorsement highlights the growing significance of these medications in addressing obesity as a critical public health issue.

1 of 2

Story summary

Oprah Winfrey responded to criticism of her walking at Paris Fashion Week, explaining she could not see well because of new sunglasses and Gayle King's broken toes.
Earlier this month, she showcased weight loss by arriving in stylish attire.
In a recent interview, she said she will take GLP-1 (glucagon-like peptide-1) weight loss medication after years of obesity and urged others to seek information and choose their paths.

1 / 2